Why Canada hasn’t been getting the new antibiotics we need to fight drug-resistant ‘superbugs’

  03 March 2022

More than one-quarter of infections in Canada fail to clear up when people are treated with standard antibiotics. This failure occurs because of a phenomenon called antimicrobial resistance (also called AMR), where bacteria and other microbes develop the ability to resist the effects of drugs designed to kill them.

These drug-resistant microbes — colloquially known as “superbugs” — are becoming increasingly common. In 2019, the World Health Organization (WHO) declared that antimicrobial resistance is among the top 10 threats to global health. And while drug resistance has long been forecasted to worsen over time, further research indicates that the problem has accelerated during the COVID-19 pandemic.

Further reading: The Conversation
Author(s): The Conversation
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed